ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Medivir Ab

Medivir Ab (0GP7)

41.70
0.00
( 0.00% )
Updated: 18:00:00

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
41.70
Bid
0.00
Ask
0.00
Volume
0.00
0.00 Day's Range 0.00
41.70 52 Week Range 41.70
Market Cap
Previous Close
41.70
Open
-
Last Trade
(O)
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
1,026
Shares Outstanding
105,371,000
Dividend Yield
-
PE Ratio
-49.19
Earnings Per Share (EPS)
-0.85
Revenue
7.66M
Net Profit
-89.32M

About Medivir Ab

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Diversified
Website
Headquarters
Huddinge, Swe
Founded
1992
Medivir Ab is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0GP7. The last closing price for Medivir Ab was SEK41.70. Over the last year, Medivir Ab shares have traded in a share price range of SEK 41.70 to SEK 41.70.

Medivir Ab currently has 105,371,000 shares outstanding. The market capitalization of Medivir Ab is SEK4.39 billion. Medivir Ab has a price to earnings ratio (PE ratio) of -49.19.

0GP7 Latest News

Medivir to present clinical pharmacokinetic data at EASL Liver Cancer Summit, further supporting the continued development of fostrox

Medivir to present clinical pharmacokinetic data at EASL Liver Cancer Summit, further supporting the continued development of fostrox PR Newswire STOCKHOLM, Jan. 15, 2024 STOCKHOLM, Jan. 15, 2024...

Medivir´s licensee, Tango Therapeutics, has dosed the first patient with TNG348, a novel USP1 inhibitor, in a phase 1/2 clinical study

Medivir´s licensee, Tango Therapeutics, has dosed the first patient with TNG348, a novel USP1 inhibitor, in a phase 1/2 clinical study PR Newswire STOCKHOLM, Jan. 4, 2024 STOCKHOLM, Jan. 4, 2024...

Fostrox + Lenvima demonstrates further improvement in durable clinical benefit in HCC, supporting the accelerated development plan

Fostrox + Lenvima demonstrates further improvement in durable clinical benefit in HCC, supporting the accelerated development plan PR Newswire STOCKHOLM, Dec. 19, 2023 Sustained disease control...

Medivir have agreed with Lonza to manufacture a fostrox GMP campaign, to be tested in 2L HCC with intent to commercialize via accelerated approval

Medivir have agreed with Lonza to manufacture a fostrox GMP campaign, to be tested in 2L HCC with intent to commercialize via accelerated approval PR Newswire STOCKHOLM, Dec. 13, 2023 STOCKHOLM...

Medivir's partner IGM Biosciences announces strategic pipeline prioritization to extend its cash runway

Medivir's partner IGM Biosciences announces strategic pipeline prioritization to extend its cash runway PR Newswire STOCKHOLM, Dec. 6, 2023 STOCKHOLM, Dec. 6, 2023 /PRNewswire/ -- Medivir AB...

Medivir to present at the Carlsquare Equity Research Investor Day

Medivir to present at the Carlsquare Equity Research Investor Day PR Newswire STOCKHOLM, Dec. 6, 2023 STOCKHOLM, Dec. 6, 2023 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical...

Bulletin from Extraordinary General Meeting in Medivir AB (publ)

Bulletin from Extraordinary General Meeting in Medivir AB (publ) PR Newswire STOCKHOLM, Dec. 1, 2023 STOCKHOLM, Dec. 1, 2023 /PRNewswire/ -- Today on 1 December 2023, Medivir AB (publ) (the...

Medivir announces updated formulation of fostrox, critical to support planned study with accelerated approval intent in second line HCC

Medivir announces updated formulation of fostrox, critical to support planned study with accelerated approval intent in second line HCC PR Newswire STOCKHOLM, Nov. 27, 2023 STOCKHOLM, Nov. 27...

Medivir to present at the Redeye Life Science Day

Medivir to present at the Redeye Life Science Day PR Newswire STOCKHOLM, Nov. 22, 2023 STOCKHOLM, Nov. 22, 2023 /PRNewswire/ -- Medivir AB (NASDAQ Stockholm: MVIR), a pharmaceutical company...

Medivir to present at the Erik Penser Bank Company Event

Medivir to present at the Erik Penser Bank Company Event PR Newswire STOCKHOLM, Nov. 21, 2023 STOCKHOLM, Nov. 21, 2023 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR), a pharmaceutical...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10041.741.741.7343441.7DE
40041.741.741.7172641.7DE
120041.741.741.7102641.7DE
260041.741.741.746541.7DE
520041.741.741.728041.7DE
1560041.741.741.712741.7DE
2600041.741.741.729941.7DE

0GP7 - Frequently Asked Questions (FAQ)

What is the current Medivir Ab share price?
The current share price of Medivir Ab is SEK 41.70
How many Medivir Ab shares are in issue?
Medivir Ab has 105,371,000 shares in issue
What is the market cap of Medivir Ab?
The market capitalisation of Medivir Ab is SEK 4.39B
What is the 1 year trading range for Medivir Ab share price?
Medivir Ab has traded in the range of SEK 41.70 to SEK 41.70 during the past year
What is the PE ratio of Medivir Ab?
The price to earnings ratio of Medivir Ab is -49.19
What is the cash to sales ratio of Medivir Ab?
The cash to sales ratio of Medivir Ab is 573.59
What is the reporting currency for Medivir Ab?
Medivir Ab reports financial results in SEK
What is the latest annual turnover for Medivir Ab?
The latest annual turnover of Medivir Ab is SEK 7.66M
What is the latest annual profit for Medivir Ab?
The latest annual profit of Medivir Ab is SEK -89.32M
What is the registered address of Medivir Ab?
The registered address for Medivir Ab is LUNASTIGEN 5, 2ND FLOOR, PO BOX 1086, HUDDINGE, SE-141 22
What is the Medivir Ab website address?
The website address for Medivir Ab is www.medivir.se
Which industry sector does Medivir Ab operate in?
Medivir Ab operates in the PHARMACEUTICAL DIVERSIFIED sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NTQEnteq Technologies Plc
1.45p
(45.00%)
17.45M
TIRTiger Royalties And Investments Plc
0.17p
(36.00%)
121.87M
QBTQuantum Blockchain Technologies Plc
2.15p
(32.31%)
195.96M
RCHReach Plc
89.50p
(24.31%)
3.58M
BANKFiinu Plc
9.25p
(23.33%)
3.87M
PODPPod Point Group Holdings Plc
10.50p
(-37.46%)
5.2M
PALMPanther Metals Plc
52.50p
(-36.36%)
182.66k
PRDPredator Oil & Gas Holdings Plc
5.75p
(-22.30%)
4.56M
ADMEAdm Energy Plc
0.175p
(-22.22%)
991.32k
GTCGetech Group Plc
1.60p
(-20.00%)
206.52k
TRPTower Resources Plc
0.0315p
(1.61%)
376.06M
PREMPremier African Minerals Limited
0.0265p
(-5.36%)
297.51M
NTVONativo Resources Plc
0.0019p
(0.00%)
271.24M
TYMTertiary Minerals Plc
0.075p
(7.14%)
220.05M
QBTQuantum Blockchain Technologies Plc
2.15p
(32.31%)
195.96M

Discussion

View Full Feed
oldrogue oldrogue 3 minutes ago
Q1 about this industrial agriculture venture IMO. 20% from Artizen might help to keep the pulse going here.

Hexas Biomass is a business based in Washington State. Has great potential and
Would fit in with some of the past “ Green “
Business ventures of KK and Paul?
PVSP
Iggy_Bot Iggy_Bot 3 minutes ago
Dem Warming
a surfer a surfer 4 minutes ago
The only difference is timing. Back to near high. Bet you 100 it breaks 4.00 to 4.25 before a retrace.
XRPUSD
DrSleep DrSleep 4 minutes ago
Your bag (your current investment value) times 10
ELTP
PEACHMAN PEACHMAN 5 minutes ago
IFUS shareholders that read the Letters to Shareholders know that multiple new international potential joint venture partners will be visiting the Napoleonville plant in 2025.

Some countries are interested in SGP+2.0 for dairy cows and cattle,

Some countries are intere
IFUS
Sankarad1 Sankarad1 5 minutes ago
Always curious about this term. What exactly does 10 bagger mean? Is it 10 times the current price or $10 per share?
ELTP
IronSeer69 IronSeer69 6 minutes ago
I saw that - an investor group put together to buy the assets of Lilium. But the deal has not closed from what I have been able to find, but it is expected to sometime this month. And I also see that Archer, Joby, EHang, Vertical Aerospace, and just a few others, are the real players remaking.
ACHR
Seminole Red Seminole Red 9 minutes ago
clock should start when ball is put in play/ HIKE....at least 1 second should come off, what if its a fake kick, does the clock run or on a 2 point try does the clock run......clock should start whenever the ball is in play.....imo.....it did NOT run last night on an extra point kick ?
glenn1919 glenn1919 9 minutes ago
CRKN........CHRO.........TOI.......TUYA..............................https://stockcharts.com/h-sc/ui?s=CRKN&p=W&yr=1&mn=3&dy=0&id=p96837884856
CHRO CRKN TOI
ANYDAZE ANYDAZE 10 minutes ago
👍
XRPUSD
FastEddie18585 FastEddie18585 11 minutes ago
You meant to say "black" Government workers, didn’t you? Or are you just speaking in code because it's MLK day?
FNMA
misterfishman misterfishman 13 minutes ago
Nothing from finra as yet
IGPK
sab63090 sab63090 14 minutes ago
gerry57

I agree totally with your post, since you made it clear that those involved with the trials are most familiar with that trial and do have a built in conflict of interest. I don't know who stated the opposite since that post was deleted and rightfully so!

As muc
AVXL
glenn1919 glenn1919 15 minutes ago
LITM....................................https://stockcharts.com/h-sc/ui?s=LITM&p=W&yr=1&mn=3&dy=0&id=p96837884856
LITM
HappyLibrarian HappyLibrarian 16 minutes ago
What I see happening is news flow coming out slowly and controlled so the price rise doesn’t happen all of a sudden.

Biotechs often let some big money players in cheap because it gives them validation and they have access to media.

So retail investors get shaken out and
NWBO
misterfishman misterfishman 17 minutes ago
True that i don't worry about it i check it from time to time and it's just a matter of time when the ceo put out another fake news so we can get out of here.
GMPR
GameStop GameStop 17 minutes ago
At the link below you can find the officially registered sec file of 1/4/2024.
You can find it in full here

https://research.secdatabase.com/CIK/1408276/Company-Name/SEVEN-ARTS-ENTERTAINMENT-INC.

Talk about the deal with Lionsgate

Enjoy the show
SAPX
glenn1919 glenn1919 17 minutes ago
LITM..................................................https://stockcharts.com/h-sc/ui?s=LITM&p=W&b=5&g=0&id=p86431144783
LITM
europa7 europa7 17 minutes ago
Real-World Use Cases of DePIN: From IoT to Supply Chain Management
https://www.rapidinnovation.io/post/real-world-use-cases-of-depin-from-iot-to-supply-chain-management

The Future of DePIN: Predictions and Trends for 2025 and Beyond
https://www.rapidinnovation.io/post/th
HSCS
Frankher Frankher 18 minutes ago
In 2025, the United States solidifies its position as a global leader in the dynamic telecommunications market, ushering in a new technological era. The widespread adoption of 5G technology is projected to reach 68% by the end of the year, serving as a critical driver of advanced connectivity and di
IQST
glenn1919 glenn1919 19 minutes ago
OSS..........................................https://stockcharts.com/h-sc/ui?s=OSS&p=W&yr=1&mn=3&dy=0&id=p96837884856
OSS
misterfishman misterfishman 19 minutes ago
Once again the better team lost.the raven beat themselves again not the other team they had chance after chance but as usual they choke and did it to themselves. They will never win another super bowl as long as they have this mentality and that's the way it is.
IGPK
FastEddie18585 FastEddie18585 23 minutes ago
It's generally acknowledged that Trump is the most corrupt POTUS ever. What you're really saying is that this time he's YOUR crook, lol. Man up and be honest about it. Trump is good for us Fannie shareholders. It's the rest of. the country I worry about as everything that happens from here on out i
FNMA
capgain capgain 24 minutes ago
GM, glad your snow wasn't too bad for you.

Enjoy the day.

Your Recent History

Delayed Upgrade Clock